4.7 Article

Association of Serum 25 (OH) Vitamin D With Chronic Kidney Disease Progression in Type 2 Diabetes

Journal

FRONTIERS IN ENDOCRINOLOGY
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2022.929598

Keywords

25-hydroxyvitamin D; type 2 diabetes mellitus; CKD progression; diabetic kidney disease; non-diabetic kidney disease

Funding

  1. National Natural Science Foundation of China [82170699, 81870469, 82100767]
  2. Natural Science Foundation of Jiangsu Province [BK20191075]
  3. PRO_Run Fund of the Nephrology Group of CEBM
  4. Project of clinical capability improvement of the First Affiliated Hospital of Nanjing Medical University
  5. 333 Project of Jiangsu Province
  6. Six Talent Peaks Project in Jiangsu Province [WSN-010]
  7. Yiluqihang .Shenmingyuanyang Medical Development and Scientific Research Fund Project on Kidney Diseases [SMYY20220301001]
  8. Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institution

Ask authors/readers for more resources

This study found that decreased levels of 25-hydroxyvitamin D (25(OH)D) in patients with type 2 diabetes mellitus (T2DM) were associated with deteriorated renal function and increased risk of chronic kidney disease (CKD) progression.
ObjectivesGrowing evidence demonstrated that vitamin D levels had been linked to type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) in light of various extraskeletal effects. Therefore, the present study aimed to evaluate the association of 25-hydroxyvitamin D [25(OH)D] level with the clinicopathological features and CKD progression in T2DM. MethodsA total of 182 patients with T2DM with CKD stages 1 through 4 (G1-G4) were retrospectively included. Identification of the serum 25(OH)D level associated with CKD progression was executed by Kaplan-Meier survival analysis and Cox proportional hazards models. We further performed sensitivity analyses with a time-weighted average (TWA) of the serum 25(OH)D level in 75 participants to reinforce the findings. ResultsThe median serum 25(OH)D level was 26 (IQR, 14; 39) nmol/L in the study participants. Median follow-up time was 42 months, during which 70 (38%) patients confronted CKD progression. Cumulative kidney outcomes were significantly higher in the lowest tertile of the serum 25(OH)D level in Kaplan-Meier analyses (P < 0.001). Consistently, the analyses of Cox proportional hazards regression models indicated a significantly greater risk for CKD progression in the lowest tertile of the serum 25(OH)D level compared with the highest tertile of the serum 25(OH)D level (P = 0.03). These relationships remained robust with further sensitivity analysis of data with TWA of the serum 25(OH)D level, showing an independent association between lower TWA of the serum 25(OH)D level and an unfavorable renal outcome in patients with T2DM with CKD. ConclusionsOur findings demonstrated that patients with T2DM with a decreased 25(OH)D level had deteriorated renal function. Both lower levels of baseline and TWA of serum 25(OH)D were associated with an increased risk of CKD progression in patients with T2DM, which suggested that the long-term maintenance of optimal vitamin D levels from early in life might be associated with reduced future risk of CKD development in T2DM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available